These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 16290080)

  • 1. Proceedings of the 4th International Conference on Inhibitors of Protein Kinases and associated workshop: modelling of specific molecular recognition processes. June 25-29, 2005. Warsaw Poland.
    Biochim Biophys Acta; 2005 Dec; 1754(1-2):1-331. PubMed ID: 16290080
    [No Abstract]   [Full Text] [Related]  

  • 2. IPK'2007. Proceedings of the 5th International Conference Inhibitors of Protein Kinases and workshop session on novel molecular design and simulation methods, Warsaw, Poland, June 23-27, 2007.
    Biochim Biophys Acta; 2008 Jan; 1784(1):1-258. PubMed ID: 18365334
    [No Abstract]   [Full Text] [Related]  

  • 3. Abstracts of the 4th International Conference of Inhibitors of Protein Kinases and the Workshop on Modelling of Specific Molecular Recognition Processes, June 25-29, 2005, Warsaw, Poland.
    Cell Mol Biol Lett; 2005; 10 Suppl 2():9-149. PubMed ID: 17352049
    [No Abstract]   [Full Text] [Related]  

  • 4. Proceedings of The Second International Conference on Inhibitors of Protein Kinases and Workshop on Computer-aided Drug Design. September 9-15, 2001. Warsaw, Poland.
    Pharmacol Ther; 2002; 93(2-3):77-317. PubMed ID: 12191623
    [No Abstract]   [Full Text] [Related]  

  • 5. IUBMB focused meeting: 10
    Poznanski J; Fabbro D
    IUBMB Life; 2020 Jun; 72(6):1094-1096. PubMed ID: 32441880
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Abstracts of the 3rd International Conference on Inhibitors of Protein Kinases, June 22-27, 2003 and Workshop on Phosphoryl-Transfer Mechanisms, June 27-29, 2003. Warsaw, Poland.
    Cell Mol Biol Lett; 2003; 8(2A):503-631. PubMed ID: 12813492
    [No Abstract]   [Full Text] [Related]  

  • 7. IPK'2003. Proceedings of the 3rd International Conference Inhibitors of Protein Kinases and Workshop Phosphoryl-Transfer Mechanisms. June 22-28, 2003, Warsaw, Poland.
    Biochim Biophys Acta; 2004 Mar; 1697(1-2):1-300. PubMed ID: 15023345
    [No Abstract]   [Full Text] [Related]  

  • 8. Proceedings of IPK 2012, the 7th International Conference on Inhibitors of Protein Kinases. August 24-27, 2012. Warsaw, Poland.
    Biochim Biophys Acta; 2013 Jul; 1834(7):1269-459. PubMed ID: 23991442
    [No Abstract]   [Full Text] [Related]  

  • 9. IPK'2001. Abstracts of the 2nd International Conference on Inhibitors of Protein Kinases and the Workshop on Computer-Aided Drug Design. September 9-15, 2001. Warsaw, Poland.
    Cell Mol Biol Lett; 2001; 6(2B):447-565. PubMed ID: 11787496
    [No Abstract]   [Full Text] [Related]  

  • 10. Advanced molecular dynamics simulation methods for kinase drug discovery.
    Aci-Sèche S; Ziada S; Braka A; Arora R; Bonnet P
    Future Med Chem; 2016 Apr; 8(5):545-66. PubMed ID: 27054816
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Methods in Enzymology. Protein kinase inhibitors in research and medicine. Preface.
    Shokat KM
    Methods Enzymol; 2014; 548():xi-xii. PubMed ID: 25399648
    [No Abstract]   [Full Text] [Related]  

  • 12. Irreversible protein kinase inhibitors: balancing the benefits and risks.
    Barf T; Kaptein A
    J Med Chem; 2012 Jul; 55(14):6243-62. PubMed ID: 22621397
    [No Abstract]   [Full Text] [Related]  

  • 13. The logic and design of analog-sensitive kinases and their small molecule inhibitors.
    Lopez MS; Kliegman JI; Shokat KM
    Methods Enzymol; 2014; 548():189-213. PubMed ID: 25399647
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Through the "gatekeeper door": exploiting the active kinase conformation.
    Zuccotto F; Ardini E; Casale E; Angiolini M
    J Med Chem; 2010 Apr; 53(7):2681-94. PubMed ID: 20000735
    [No Abstract]   [Full Text] [Related]  

  • 15. Protein kinase homology models: recent developments and results.
    Tuccinardi T; Martinelli A
    Curr Med Chem; 2011; 18(19):2848-53. PubMed ID: 21651494
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peptides targeting protein kinases: strategies and implications.
    Kaidanovich-Beilin O; Eldar-Finkelman H
    Physiology (Bethesda); 2006 Dec; 21():411-8. PubMed ID: 17119154
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The 'retro-design' concept for novel kinase inhibitors.
    Müller G; Sennhenn PC; Woodcock T; Neumann L
    IDrugs; 2010 Jul; 13(7):457-66. PubMed ID: 20582870
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The evolution of protein kinase inhibitors from antagonists to agonists of cellular signaling.
    Dar AC; Shokat KM
    Annu Rev Biochem; 2011; 80():769-95. PubMed ID: 21548788
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure-based design and optimization of 2-aminothiazole-4-carboxamide as a new class of CHK1 inhibitors.
    Huang X; Cheng CC; Fischmann TO; Duca JS; Richards M; Tadikonda PK; Reddy PA; Zhao L; Siddiqui MA; Parry D; Davis N; Seghezzi W; Wiswell D; Shipps GW
    Bioorg Med Chem Lett; 2013 May; 23(9):2590-4. PubMed ID: 23535330
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design strategies, structure activity relationship and mechanistic insights for purines as kinase inhibitors.
    Sharma S; Singh J; Ojha R; Singh H; Kaur M; Bedi PMS; Nepali K
    Eur J Med Chem; 2016 Apr; 112():298-346. PubMed ID: 26907156
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.